Alejandro Zaffaroni, a biotech entrepreneur who was involved in the development of products as disparate as the birth control pill and DNA chips, has died, the New York Times reports. He was 91. Zaffaroni, a biochemist by training, started at least 10 companies throughout his career, including Affymetrix, the Times adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.